242 related articles for article (PubMed ID: 31117294)
1. NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.
Del Coco L; Vergara D; De Matteis S; Mensà E; Sabbatinelli J; Prattichizzo F; Bonfigli AR; Storci G; Bravaccini S; Pirini F; Ragusa A; Casadei-Gardini A; Bonafè M; Maffia M; Fanizzi FP; Olivieri F; Giudetti AM
J Clin Med; 2019 May; 8(5):. PubMed ID: 31117294
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
3. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
4. Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors.
Wang M; Ou Y; Yuan XL; Zhu XF; Niu B; Kang Z; Zhang B; Ahmed A; Xing GQ; Su H
World J Diabetes; 2024 Jan; 15(1):53-71. PubMed ID: 38313852
[TBL] [Abstract][Full Text] [Related]
5. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
6. A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness.
Wolak-Dinsmore J; Gruppen EG; Shalaurova I; Matyus SP; Grant RP; Gegen R; Bakker SJL; Otvos JD; Connelly MA; Dullaart RPF
Clin Biochem; 2018 Apr; 54():92-99. PubMed ID: 29432757
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
8.
Lin HT; Cheng ML; Lo CJ; Lin G; Lin SF; Yeh JT; Ho HY; Lin JR; Liu FC
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31248127
[TBL] [Abstract][Full Text] [Related]
9. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
[TBL] [Abstract][Full Text] [Related]
10. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.
Piccolo BD; Graham JL; Stanhope KL; Fiehn O; Havel PJ; Adams SH
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E958-69. PubMed ID: 27094034
[TBL] [Abstract][Full Text] [Related]
11. Metabolic impairments associated with type 2 diabetes mellitus and the potential effects of exercise therapy: An exploratory randomized trial based on untargeted metabolomics.
Zhang F; Chen X; Yang M; Shen X; Wang Y; Zhong D; Zeng F; Jin R
PLoS One; 2024; 19(3):e0300593. PubMed ID: 38517904
[TBL] [Abstract][Full Text] [Related]
12. Unveiling novel metabolic alterations in postmenopausal osteoporosis and type 2 diabetes mellitus through NMR-based metabolomics: A pioneering approach for identifying early diagnostic markers.
Kaur S; Kumari P; Singh G; Joshi N; Kaur T; Dhiman V; Singh G; Sachdeva N; Kumar D; Barnwal RP; Bhadada SK
J Proteomics; 2024 Jun; 302():105200. PubMed ID: 38772440
[TBL] [Abstract][Full Text] [Related]
13. Altered amino acid metabolism between coronary heart disease patients with and without type 2 diabetes by quantitative
Zhang L; Zhang Y; Ma Z; Zhu Y; Chen Z
J Pharm Biomed Anal; 2021 Nov; 206():114381. PubMed ID: 34583124
[TBL] [Abstract][Full Text] [Related]
14. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
[TBL] [Abstract][Full Text] [Related]
15. Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications.
Tanase DM; Gosav EM; Botoc T; Floria M; Tarniceriu CC; Maranduca MA; Haisan A; Cucu AI; Rezus C; Costea CF
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762992
[TBL] [Abstract][Full Text] [Related]
16. Lower serum branched-chain amino acid catabolic intermediates are predictive signatures specific to patients with diabetic foot.
Wang T; Wang M; Liu L; Xie F; Wu X; Li L; Ji J; Wu D
Nutr Res; 2023 Nov; 119():33-42. PubMed ID: 37716292
[TBL] [Abstract][Full Text] [Related]
17. Metabolite biomarkers of type 2 diabetes mellitus and pre-diabetes: a systematic review and meta-analysis.
Long J; Yang Z; Wang L; Han Y; Peng C; Yan C; Yan D
BMC Endocr Disord; 2020 Nov; 20(1):174. PubMed ID: 33228610
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy to postpartum transition of serum metabolites in women with gestational diabetes.
Chorell E; Hall UA; Gustavsson C; Berntorp K; Puhkala J; Luoto R; Olsson T; Holmäng A
Metabolism; 2017 Jul; 72():27-36. PubMed ID: 28641781
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy.
Rojas DR; Kuner R; Agarwal N
J Mol Med (Berl); 2019 Jun; 97(6):845-854. PubMed ID: 30949723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
